WuXi Biologics (Cayman) Inc. (WXXWY)
OTCMKTS
· Delayed Price · Currency is USD
6.79
-0.13 (-1.88%)
Apr 1, 2025, 2:43 PM EST
WuXi Biologics Employees
WuXi Biologics had 12,740 employees as of December 31, 2023. The number of employees increased by 367 or 2.97% compared to the previous year.
Employees
12,740
Change (1Y)
367
Growth (1Y)
2.97%
Revenue / Employee
$203,466
Profits / Employee
$36,564
Market Cap
14.11B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Endo Inc. | 3,116 |
Elite Pharmaceuticals | 64 |
Glass House Brands | 413 |
Northwest Biotherapeutics | 25 |
CytoDyn | 9 |
Silence Therapeutics | 116 |
American Oncology Network | 1,525 |
Longduoduo Company | 49 |
WuXi Biologics News
- 5 days ago - Wuxi Biologics ADR reports FY results - Seeking Alpha
- 7 days ago - WuXi Biologics Reports Solid 2024 Annual Results and Expects Accelerated Growth in 2025 - PRNewsWire
- 8 days ago - WuXi Biologics Celebrates Eighth Consecutive CDMO Leadership Award Win - GuruFocus
- 8 days ago - WuXi Biologics Receives CDMO Leadership Awards for Eighth Consecutive Year - PRNewsWire
- 11 days ago - WuXi Biologics Named to CDP Water Security "A List" for Second Consecutive Year - PRNewsWire
- 21 days ago - WuXi Biologics Included in S&P Global Sustainability Yearbook 2025 - PRNewsWire
- 4 weeks ago - WuXi Biologics Launches EffiX⢠Platform to Enhance Protein and DNA Production - GuruFocus
- 4 weeks ago - WuXi Biologics Launches EffiX™ Microbial Expression Platform to Boost Recombinant Protein and Plasmid DNA Production - PRNewsWire